ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATYR ATYR PHARMA INC

盘前交易 12-23 05:45:42 EST

3.35

+0.20

+6.35%

最高3.35	最低3.13	成交量162.70万
今开3.15	昨收3.15	日振幅6.98%
总市值2.81亿	流通市值2.58亿	总股本8,394万
成交额539.16万	换手率2.12%	流通股本7,692万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATYR","market":"US","secType":"STK","nameCN":"ATYR PHARMA INC","latestPrice":3.35,"timestamp":1734728400000,"preClose":3.15,"halted":0,"volume":1626967,"delay":0,"floatShares":76915100,"shares":83942407,"eps":-0.933059,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.2,"latestTime":"12-23 05:45:42 EST","open":3.15,"high":3.35,"low":3.13,"amount":5391567.544879,"amplitude":0.069841,"askPrice":4.34,"askSize":100,"bidPrice":3.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.933059,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1430971200000,"adjPreClose":3.35,"postHourTrading":{"tag":"盘后","latestPrice":3.39,"preClose":3.35,"latestTime":"19:57 EST","volume":147305,"amount":493491.3805,"timestamp":1734742633677},"volumeRatio":1.7079680500548997,"impliedVol":0.1251,"impliedVolPercentile":0.0072},"requestUrl":"/m/hq/s/ATYR","defaultTab":"news","newsList":[{"id":"2492616552","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.23%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492616552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492616552?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:58","pubTimestamp":1734364702,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时58分，Atyr Pharma, Inc.股票出现异动，股价快速拉升5.23%。截至发稿，该股报3.22美元/股，成交量18.586万股，换手率0.22%，振幅6.47%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216235823984c7318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216235823984c7318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2490757869","title":"Atyr Pharma, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490757869","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490757869?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:39","pubTimestamp":1733931540,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时39分，Atyr Pharma, Inc.股票出现异动，股价急速下跌5.02%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Candel Therapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为430.41%、167.46%、102.29%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Candel Therapeutics, Inc.、Biora Therapeutics, Inc.，振幅分别为127.38%、104.12%、69.68%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121123390095e8fb1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121123390095e8fb1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CADL","BK4139","ATYR"],"gpt_icon":0},{"id":"2490001769","title":"Atyr Pharma, Inc.盘中异动 早盘快速下挫6.23%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490001769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490001769?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:41","pubTimestamp":1733845294,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时41分，Atyr Pharma, Inc.股票出现波动，股价快速下跌6.23%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.42%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1927.51%、446.40%、130.54%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Uniqure N.V.，振幅分别为154.91%、131.78%、44.00%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023413595e8b1db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023413595e8b1db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2490794197","title":"Atyr Pharma, Inc.盘中异动 早盘大幅拉升5.36%报3.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490794197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490794197?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:51","pubTimestamp":1733755884,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时51分，Atyr Pharma, Inc.股票出现波动，股价大幅上涨5.36%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为3799.35%、28.32%、25.55%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Metagenomi, Inc.，振幅分别为59.05%、41.44%、37.84%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209225124a1e0b362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209225124a1e0b362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2489231629","title":"Atyr Pharma, Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489231629?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:04","pubTimestamp":1733497458,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时04分，Atyr Pharma, Inc.股票出现异动，股价快速上涨5.05%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Dermata Therapeutics Inc C/Wts 、Cardio Diagnostics Holdings Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为44.50%、33.47%、22.16%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、Aprea Therapeutics, Inc.，振幅分别为27.68%、24.33%、18.99%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230419a1d98106&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230419a1d98106&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2488944720","title":"Atyr Pharma, Inc.盘中异动 大幅跳水5.34%报3.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488944720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488944720?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:25","pubTimestamp":1733239530,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时25分，Atyr Pharma, Inc.股票出现异动，股价急速跳水5.34%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Janux Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为139.57%、105.78%、99.31%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.，振幅分别为69.23%、51.13%、48.91%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203232530a269b1e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203232530a269b1e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2488917615","title":"试验失败后，Roivant 将停止肺病药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917615","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488917615?lang=zh_cn&edition=full","pubTime":"2024-12-03 21:32","pubTimestamp":1733232769,"startTime":"0","endTime":"0","summary":"更新 2-试验失败后，Roivant 将停止肺病药物开发第5段增加了首席执行官的话，第2段增加了试验细节，更新了股价路透社12月3日 - Roivant ROIV.O将停止开发治疗一种罕见肺病的药物，因为该药物在一项中期试验中未能显示出对患者的治疗效果。Roivant公司的股票在盘前交易中下跌了2.3%。药物开发商aTyr Pharma的ATYR.O efzofitimod也正在接受治疗肺肉样肿病的测试，目前处于后期开发阶段。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3T3N40Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ATYR","ROIV"],"gpt_icon":0},{"id":"2486875220","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486875220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486875220?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:34","pubTimestamp":1732721665,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时34分，Atyr Pharma, Inc.股票出现波动，股价快速拉升5.47%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为934.55%、87.15%、26.16%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为66.67%、52.60%、35.46%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127233425abe387f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127233425abe387f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2486036742","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.20%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486036742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486036742?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:41","pubTimestamp":1732549306,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时41分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.20%。截至发稿，该股报3.19美元/股，成交量15.3827万股，换手率0.18%，振幅3.96%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为2.16%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234146abde1d0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234146abde1d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2485293250","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485293250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485293250?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:24","pubTimestamp":1732292678,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时24分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.03%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Replimune Group, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1767.19%、123.30%、90.41%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.，振幅分别为63.64%、62.35%、45.86%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123002438abd7c176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123002438abd7c176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2484672648","title":"Atyr Pharma, Inc.盘中异动 早盘快速上涨5.34%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672648?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:28","pubTimestamp":1731943709,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时28分，Atyr Pharma, Inc.股票出现波动，股价快速拉升5.34%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃，换手率分别为608.50%、557.42%、369.90%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为217.24%、75.18%、73.24%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232829971a7376&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232829971a7376&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2483306160","title":"Atyr Pharma, Inc.2024财年第三财季实现净利润-17.26百万美元，同比减少52.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306160?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Atyr Pharma, Inc.公布财报，公告显示公司2024财年第三财季净利润为-17.26百万美元，同比减少52.20%；其中营业收入为0.00美元，每股基本收益为-0.23美元。从资产负债表来看，Atyr Pharma, Inc.总负债26.48百万美元，其中短期债务1.21百万美元，资产负债比为3.46，流动比率为5.41。机构评级：截至2024年11月16日，当前有7家机构对Atyr Pharma, Inc.目标价做出预测，其中目标均价为21.29美元，其中最低目标价为9.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000320abc5160b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000320abc5160b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR"],"gpt_icon":0},{"id":"2483680050","title":"Atyr Pharma, Inc.盘中异动 股价大跌5.40%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483680050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483680050?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:09","pubTimestamp":1731596976,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时09分，Atyr Pharma, Inc.股票出现波动，股价快速跳水5.40%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Abpro Holdings, Inc涨幅较大，Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为2407.46%、49.16%、34.83%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Abpro Holdings, Inc，振幅分别为75.00%、73.28%、72.79%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114230936a237e72f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114230936a237e72f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","BK4007","BK4139","ATYR"],"gpt_icon":0},{"id":"2483088166","title":"Atyr Pharma, Inc.盘中异动 大幅上涨5.87%报3.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483088166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483088166?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:33","pubTimestamp":1731508394,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时33分，Atyr Pharma, Inc.股票出现异动，股价快速上涨5.87%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为331.75%、179.99%、85.09%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Kairos Pharma, Ltd.、Mersana Therapeutics, Inc.，振幅分别为14.89%、14.12%、13.00%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223314971a647c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223314971a647c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2481101684","title":"Atyr Pharma, Inc.盘中异动 急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101684?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:33","pubTimestamp":1731076395,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时33分，Atyr Pharma, Inc.股票出现波动，股价快速下挫5.16%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Fortrea Holdings Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为389.18%、16.55%、14.20%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为17.11%、16.52%、14.96%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822331598e41788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822331598e41788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2481324301","title":"Atyr Pharma, Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481324301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481324301?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:39","pubTimestamp":1731004756,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时39分，Atyr Pharma, Inc.股票出现波动，股价急速下挫5.01%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为932.80%、491.86%、119.29%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为193.53%、72.18%、68.89%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110802391698e4144c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110802391698e4144c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2481460474","title":"aTyr Pharma Inc   预计每股亏损22美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481460474","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481460474?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:54","pubTimestamp":1730901265,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc    预计将在11月7日公布截至0001年1月1日的业绩报告(估计)，季度收入将出现下降。* 根据 LSEG 数据，6 位分析师的平均预期显示，这家总部位于加利福尼亚州圣迭戈的公司的营收预计将从去年同期的 35.3 万美元下降 95.3%，至 16.67 万美元。* LSEG 分析师对 aTyr Pharma Inc 的平均预期是每股亏损 22 美分。* 华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 19.50 美元，高于其上次收盘价 3.15 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"aTyr Pharma Inc   预计每股亏损22美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR"],"gpt_icon":0},{"id":"2481353705","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481353705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481353705?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:07","pubTimestamp":1730736464,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时07分，Atyr Pharma, Inc.股票出现异动，股价快速拉升5.26%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为294.21%、268.84%、70.92%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited，振幅分别为52.25%、45.39%、39.13%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110500074498e4051c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110500074498e4051c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2479288401","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479288401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479288401?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:39","pubTimestamp":1730209145,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时39分，Atyr Pharma, Inc.股票出现异动，股价快速拉升5.28%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为563.16%、263.84%、154.35%，振幅较大的相关个股有Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Coya Therapeutics, Inc.，振幅分别为54.10%、25.95%、17.17%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213905a1f5a5e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213905a1f5a5e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2478955689","title":"Atyr Pharma, Inc.盘中异动 快速上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478955689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478955689?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:08","pubTimestamp":1729872539,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时08分，Atyr Pharma, Inc.股票出现异动，股价急速拉升5.36%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为822.38%、746.12%、233.89%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Iterum Therapeutics Plc、Elevai Labs, Inc.，振幅分别为91.58%、90.60%、85.68%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102600085998e3e8c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102600085998e3e8c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atyrpharma.com","stockEarnings":[{"period":"1week","weight":0.0948},{"period":"1month","weight":0.1204},{"period":"3month","weight":0.8407},{"period":"6month","weight":1.2483},{"period":"1year","weight":1.5188},{"period":"ytd","weight":1.3759}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"aTyr Pharma, Inc.于2005年9月8日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用进化智能将tRNA合成酶生物学转化为纤维化和炎症的新疗法。tRNA合成酶是古老的、必需的蛋白质，它们已经进化出新的结构域，在人类的胞外调节不同的途径。该公司的发现平台专注于通过发现由所有20种tRNA合成酶衍生的结构域专有库驱动的信号通路来解锁隐藏的治疗干预点。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.022427},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.026924},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.036889},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.052458},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.096577},{"month":6,"riseRate":0.5,"avgChangeRate":-0.034182},{"month":7,"riseRate":0.5,"avgChangeRate":0.005168},{"month":8,"riseRate":0.1,"avgChangeRate":-0.079736},{"month":9,"riseRate":0.5,"avgChangeRate":0.102256},{"month":10,"riseRate":0.3,"avgChangeRate":0.01241},{"month":11,"riseRate":0.6,"avgChangeRate":0.036606},{"month":12,"riseRate":0.3,"avgChangeRate":-0.075274}],"exchange":"NASDAQ","name":"ATYR PHARMA INC","nameEN":"ATYR PHARMA INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ATYR PHARMA INC,ATYR,ATYR PHARMA INC股票,ATYR PHARMA INC股票老虎,ATYR PHARMA INC股票老虎国际,ATYR PHARMA INC行情,ATYR PHARMA INC股票行情,ATYR PHARMA INC股价,ATYR PHARMA INC股市,ATYR PHARMA INC股票价格,ATYR PHARMA INC股票交易,ATYR PHARMA INC股票购买,ATYR PHARMA INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}